Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

BUY
$197.69 - $227.29 $533,169 - $613,001
2,697 New
2,697 $613,000
Q2 2023

Jul 25, 2023

BUY
$211.93 - $241.33 $90,070 - $102,565
425 Added 17.37%
2,872 $693,000
Q1 2023

Apr 20, 2023

BUY
$213.32 - $257.83 $2,773 - $3,351
13 Added 0.53%
2,447 $561,000
Q4 2022

Jan 25, 2023

BUY
$203.72 - $248.97 $495,854 - $605,992
2,434 New
2,434 $0
Q2 2022

Jul 18, 2022

BUY
$213.86 - $277.87 $4,918 - $6,391
23 Added 0.98%
2,368 $555,000
Q1 2022

Apr 20, 2022

SELL
$259.82 - $298.18 $310,484 - $356,325
-1,195 Reduced 33.76%
2,345 $618,000
Q4 2021

Jan 04, 2022

BUY
$271.6 - $314.21 $241,180 - $279,018
888 Added 33.48%
3,540 $1.11 Million
Q3 2021

Nov 04, 2021

SELL
$274.82 - $308.34 $386,122 - $433,217
-1,405 Reduced 34.63%
2,652 $746,000
Q2 2021

Jul 28, 2021

SELL
$251.87 - $278.14 $73,042 - $80,660
-290 Reduced 6.67%
4,057 $1.12 Million
Q1 2021

Apr 21, 2021

BUY
$204.88 - $255.03 $317,768 - $395,551
1,551 Added 55.47%
4,347 $1.11 Million
Q4 2020

Jan 27, 2021

BUY
$186.91 - $214.42 $95,697 - $109,783
512 Added 22.42%
2,796 $569,000
Q3 2020

Oct 19, 2020

BUY
$167.03 - $201.3 $65,976 - $79,513
395 Added 20.91%
2,284 $430,000
Q2 2020

Jul 30, 2020

SELL
$113.31 - $182.44 $108,890 - $175,324
-961 Reduced 33.72%
1,889 $314,000
Q1 2020

Apr 28, 2020

BUY
$104.32 - $195.28 $62,487 - $116,972
599 Added 26.61%
2,850 $360,000
Q4 2019

Jan 16, 2020

BUY
$163.48 - $173.61 $35,475 - $37,673
217 Added 10.67%
2,251 $381,000
Q3 2019

Oct 15, 2019

BUY
$159.77 - $178.1 $38,983 - $43,456
244 Added 13.63%
2,034 $342,000
Q4 2018

Feb 12, 2019

BUY
$120.82 - $174.09 $36,850 - $53,097
305 Added 20.54%
1,790 $226,000
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $25,150 - $28,240
150 Added 11.24%
1,485 $258,000
Q2 2018

Aug 13, 2018

BUY
$160.33 - $189.41 $214,040 - $252,862
1,335 New
1,335 $240,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Camelot Portfolios, LLC Portfolio

Follow Camelot Portfolios, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.